MOLECULAR GENETIC EVENTS IN LUNG CANCER
MOLECULAR GENETIC EVENTS IN LUNG CANCER
批准号:
3853209
负责人:
B E JOHNSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
atrial natriuretic peptide gene expression genetic mapping genetic markers high performance liquid chromatography histopathology hormone receptor human tissue hyponatremia lung neoplasms messenger RNA molecular genetics molecular oncology neoplasm /cancer genetics neoplastic cell oncogenes peptide hormone biosynthesis small cell lung cancer tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A. We have recently reported atrial natriuretic factor mRNA expression
and immunoreactivity in tumor and tumor cell lines from small cell lung
cancer patients with hyponatremia who did not produce arginine
vasopressin. High pressure liquid chromoatography (HPLC) analyses of the
tumor cell lines and tumors from patients with hyponatremia and mRNA
expression of atrial natriuretic factor have revealed that intracellular
and extracellular peptide appears to be the 28 amino acid form of atrial
natriuretic peptide, the form that normally circulates in human plasma.
These studies are the first to characterize the ectopic production of
atrial natriuretic peptide in small cell lung cancer patients and may
have identified the third factor (natriuretic factor) that has been
hypothesized in the syndrome of inappropriate antidiuretic hormone
(SIADH). The receptor for atrial natriuretic factor is also present on
small cell lung cancer cells and the cells respond to exogenously added
atrial natriuretic factor with an increase in intracellular cGMP,
similar to the normal receptors on vascular smooth muscle cells.
Therefore, there appear to be functional ANF receptors on the surface of
small cell lung cancer cells.
B. We reviewed the clinical course of 234 lung cancer patients. In
contrast to none of the 123 non-small cell lung cancer (NSCLC) patients,
18 of 111 (16%) small cell lung cancer patients had hyponatremia. Ten of
these 18 had tumor cell lines available and 8 expressed ANF mRNA, 8
expressed AVP mRNA, and 6 of 10 cell lines produced both ANF and AVP
mRNA. All of the 10 cell lines produced ANF mRNA, AVP mRNA, or both.
Studies of 10 tumor cell lines from the 93 SCLC patients without
hyponatremia showed 9 produced ANF mRNA and one produced AVP mRNA. From
these studies we have observed that all tumor cell lines studied from
SCLC patients with hyponatremia produce ANF mRNA or AVP mRNA, or both.
Atrial natriuretic peptide may be the previously hypothesized third
factor and play an important role in the pathogenesis of hyponatremia in
some patients with SIADH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IN VITRO DRUG TESTING FOR LIMITED SCLC AND PHASE I DRUG DEVELOPMENT
-
批准号:3939554
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
MOLECULAR GENETIC EVENTS IN LUNG CANCER
-
批准号:3838085
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
IN VITRO DRUG TESTING FOR LIMITED SCLC AND PHASE I DRUG DEVELOPMENT
-
批准号:3916620
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
MOLECULAR GENETIC EVENTS IN LUNG CANCER
-
批准号:3916618
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
IN VITRO DRUG TESTING FOR LIMITED SCLC AND PHASE I DRUG DEVELOPMENT
-
批准号:3853211
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
TREATMENT OF PATIENTS WITH LUNG CANCER
-
批准号:2456837
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
IN VITRO DRUG TESTING FOR LIMITED SCLC AND PHASE I DRUG DEVELOPMENT
-
批准号:3874443
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
TREATMENT OF PATIENTS WITH LUNG CANCER
-
批准号:6163420
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
TREATMENT OF PATIENTS WITH SMALL CELL LUNG CANCER
-
批准号:3752361
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
MOLECULAR GENETIC EVENTS IN LUNG CANCER
-
批准号:3752360
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
MOLECULAR GENETIC EVENTS IN LUNG CANCER
-
批准号:3774600
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
MOLECULAR GENETIC EVENTS IN LUNG CANCER
-
批准号:3874441
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
HYPONATREMIA OF MALIGNANCY
-
批准号:6163433
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
HYPONATREMIA OF MALIGNANCY
-
批准号:6163370
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
TREATMENT OF PATIENTS WITH LUNG CANCER
-
批准号:6163285
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
CLINICAL IMPACT OF MYC FAMILY GENES IN LUNG CANCER
-
批准号:3963283
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
TREATMENT OF PATIENTS WITH SMALL CELL LUNG CANCER
-
批准号:5201284
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
HYPONATREMIA OF MALIGNANCY
-
批准号:2456845
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
MOLECULAR GENETIC EVENTS IN LUNG CANCER
-
批准号:3939552
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
TREATMENT OF PATIENTS WITH SMALL CELL LUNG CANCER
-
批准号:3774601
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B E JOHNSON
-
依托单位:
海外基金